ALK

ALK inhibitors cover anaplastic lymphoma kinase and activin receptor-like kinases, two unrelated groups named ALK. Anaplastic lymphoma kinase was identified in 1994 as a tyrosine kinase fused to nucleophosmin (NPM) in a non-Hodgkin lymphoma. In 2007 a fusion with echinoderm microtubule-associated protein-like 4 (EML4) was found in non-small-cell lung cancer. Crizotinib, TAE684, brigatinib and entrectinib inhibit anaplastic lymphoma kinase, and entrectinib also blocks tropomyosin receptor kinases (Trk). Activin receptor-like kinases (ALKs) are type I receptors for transforming growth factor beta (TGF-β) family ligands. A 83-01 inhibits ALK4, ALK5 and ALK7 and blocks Smad signaling by TGF-β. Vactosertib also targets ALK4 and ALK5, while LDN193189 and DMH-1 inhibit the bone morphogenetic protein receptor ALK2.

Items 1-25 of 150

  • A 83-01
    Cat. No.
    A12358

    A 83-01

    A83-01 is a selective inhibitor of the transforming growth factor-beta type I receptor ALK5, the Nodal receptor ALK4, and the nodal receptor ALK7

    1 mg
    $35.00
    5 mg
    $45.00
    All 7 sizes
  • Crizotinib
    Cat. No.
    A10712

    Crizotinib (PF-2341066)

    Synonyms: PF-2341066

    PF-2341066 (Crizotinib) is an inhibitor of the c-Met kinase and the NPM-ALK. PF-2341066 inhibited cell proliferation in ALK-positive ALCL cells (IC50s=30 nM).

    5 mg
    $25.00
    10 mg
    $40.00
    All 8 sizes
  • LDN193189
    Cat. No.
    A11205

    LDN193189

    LDN193189 is a highly potent small molecule BMP inhibitor that inhibits BMP type I receptors ALK2 (IC50: 5 nM), ALK3 (IC50: 30 nM) and ALK6 (TGFβ1/BMP signaling) and subsequent SMAD phosphorylation.

    2 mg
    $35.00
    5 mg
    $60.00
    All 8 sizes
  • TAE684
    Cat. No.
    A10662

    TAE684

    Synonyms: NVP-TAE684

    TAE684 is a inhibitor of ALK and also a potent inhibitor of LRRK2 kinase activity (IC(50) of 7.8nM against wild-type LRRK2, 6.1nM against the G2019S mutant).

    2 mg
    $45.00
    5 mg
    $75.00
    All 6 sizes
  • Vactosertib
    Cat. No.
    A14213

    Vactosertib (EW-7197)

    Synonyms: EW7197

    EW-7197 is a highly potent, selective, and orally bioavailable TGF-β I receptor ALK4/ALK5 inhibitor with IC50 of 13 nM and 11 nM, respectively

    2 mg
    $30.00
    5 mg
    $55.00
    All 10 sizes
  • GSK1838705A
    Cat. No.
    A11175

    GSK1838705A

    GSK1838705A is a small-molecule kinase inhibitor that inhibits IGF-IR and the insulin receptor with IC50s of 2.0 and 1.6 nmol/L, respectively.

    1 mg
    $25.00
    2 mg
    $40.00
    All 8 sizes
  • DMH-1
    Cat. No.
    A12820

    DMH-1

    DMH-1 is a selective inhibitor of the bone morphogenic protein (BMP) ALK2 receptor (IC50 = 108 nM).

    5 mg
    $45.00
    10 mg
    $75.00
    All 7 sizes
  • Brigatinib
    Cat. No.
    A13450

    Brigatinib (AP26113)

    Synonyms: AP-26113

    Brigatinib (AP26113) is a potent and selective ALK (IC50, 0.6 nM) and ROS1 (IC50, 0.9 nM) inhibitor. It also inhibits ROS1, FLT3, and mutant variants of FLT3 (D835Y) and EGFR with lower potentcy.

    2 mg
    $25.00
    5 mg
    $35.00
    All 8 sizes
  • Entrectinib
    Cat. No.
    A15801

    Entrectinib

    Synonyms: RXDX-101; NMS E628

    Entrectinib, also known as RXDX-101 and NMS-E628, is an oral small molecule inhibitor of TrkA, TrkB and TrkC, as well as ROS1 and ALK, with high potency and selectivity.

    2 mg
    $30.00
    5 mg
    $45.00
    All 8 sizes
  • Alectinib Hydrochloride
    Cat. No.
    A18000

    Alectinib Hydrochloride

    Synonyms: CH5424802 Hydrochloride; CH 5424802; RO5424802 Hydrochloride; RO 5424802; AF-802 Hydrochloride

    Alectinib Hydrochloride (CH5424802 Hydrochloride; RO5424802 Hydrochloride; AF-802 Hydrochloride) is a potent, selective, and orally available ALK inhibitor with an IC50 of 1.9 nM and a Kd value of 2.4 nM (in an ATP-competitive manner), and also inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively.

    5 mg
    $30.00
    10 mg
    $45.00
    All 7 sizes
  • SB 525334
    Cat. No.
    A10827

    SB 525334

    SB525334 is a selective inhibitor of transforming growth factor-β receptor I (ALK5, TGF-βRI) (IC50 = 14.3 nM). Inhibits TGF-β1-induced smad2/3 nuclear localization and TGF-βRI-induced mRNA expression in kidney cells

    5 mg
    $25.00
    10 mg
    $45.00
    All 7 sizes
  • Alectinib
    Cat. No.
    A11134

    Alectinib (CH5424802)

    Synonyms: CH-5424802

    Alectinib (CH5424802) is a potent, selective, and orally available ALK inhibitor with a unique chemical scaffold, showing preferential antitumor activity against cancers with gene alterations of ALK.

    2 mg
    $30.00
    5 mg
    $55.00
    All 7 sizes
  • SB-505124
    Cat. No.
    A11157

    SB-505124

    SB-505124 is a selective inhibitor of transforming growth factor-β type I receptor (ALK5), ALK4 and ALK7 (IC50 values are 47 and 129 nM for ALK5 and ALK4 respectively).

    1 mg
    $25.00
    2 mg
    $40.00
    All 9 sizes
  • ASP3026
    Cat. No.
    A11773

    ASP3026

    ASP3026 is a novel and selective inhibitor for the ALK kinase. ASP3026 potently inhibited ALK kinase activity and was more selective than crizotinib in a Tyr-kinase panel.

    5 mg
    $25.00
    10 mg
    $40.00
    All 7 sizes
  • ALK-IN-1
    Cat. No.
    A11948

    ALK-IN-1 (Brigatinib analog, AP26113 analog)

    Synonyms: AP-26113; Brigatinib analog; AP26113 analog

    ALK-IN-1, an analog of AP26113, is an orally-available, potent, and selective inhibitor of ALK with a potency of 0.62 nM against wild-type and activity against a wide range of mutants, including the crizotinib-resistant L1196M line.

    5 mg
    $35.00
    10 mg
    $55.00
    All 8 sizes
  • Ceritinib
    Cat. No.
    A13238

    Ceritinib (LDK-378)

    Synonyms: LDK378

    LDK378 is a highly selective, orally bioavailable and ATP-competitive small molecule inhibitor of ALK (Anaplastic Lymphoma Kinase), a receptor tyrosine kinase considered to be an important lung cancer drug target.

    5 mg
    $35.00
    10 mg
    $55.00
    All 10 sizes
  • ALK2-IN-2
    Cat. No.
    A13604

    ALK2-IN-2

    ALK2-IN-2 is a potent and selective inhibitor of activin receptor-like kinase 2 (ALK2) with an IC50 of 9 nM, and over 700-fold selectivity against ALK3.

    1 mg
    $50.00
    5 mg
    $130.00
    All 8 sizes
  • CEP-28122
    Cat. No.
    A13744

    CEP-28122

    CEP-28122 is a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.

    1 mg
    $45.00
    2 mg
    $70.00
    All 5 sizes
  • Lorlatinib
    Cat. No.
    A14207

    Lorlatinib (PF-06463922)

    Synonyms: PF 06463922

    Lorlatinib (PF-06463922) is a potent, dual ALK/ROS1 inhibitor with Ki of <0.02 nM, <0.07 nM, and 0.7 nM for ROS1, ALK (WT), and ALK (L1196M), respectively.

    1 mg
    $20.00
    5 mg
    $55.00
    All 8 sizes
  • WZ4003
    Cat. No.
    A14312

    WZ4003

    WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2

    5 mg
    $35.00
    10 mg
    $65.00
    All 8 sizes
  • A 77-01
    Cat. No.
    A14436

    A 77-01

    A 77-01 is a potent inhibitor of TGF-β type I receptor superfamily activin-like kinase ALK5 with IC50 of 25 nM.

    1 mg
    $35.00
    5 mg
    $90.00
    All 7 sizes

Items 1-25 of 150

Added to your cart

View Cart Checkout

    Loading...